Experts Explain Impact of Trastuzumab Deruxtecan Approval in HER2+ Breast Cancer
Pharma & biotech2020-03-26
26 Views
Faculty voice their opinion on the clinical utility of trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
BREAKING NEWS: Herbal Works Inc. Continues Social Media Marketing Campaign with Launch of YouTube Channel
